unknown
Stage
2
Investors
About
Cyclothe is dedicated to developing life-changing medicines for patients and families living with rare and neurological disorders, focusing on diseases such as Niemann-Pick Disease Type C and Alzheimer’s Disease.
Explore Cyclothe's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.